Print
Health Care

PPD Launches Center Focusing On Rare Disease, Pediatric Areas

By Vicky Janowski, posted Feb 28, 2017
Wilmington-based Pharmaceutical Product Development LLC on Tuesday announced a project to consolidate its efforts in the rare disease and pediatric drug markets.
 
The Rare Disease and Pediatric Center of Excellence will “oversee all rare disease and pediatric-related drug development activities” for the company, according to a news release.
 
The center’s team, a group of pharmaceutical and clinical research professionals with experience in the areas, will focus on “addressing the specific challenges presented by the small, widely dispersed populations of rare disease and pediatric patients,” the release stated. “This group of functional experts has been assembled to support end-to-end clinical trial solutions in such areas as feasibility strategy, clinical information, biostatistics, pharmacovigilance, lab operations and business analytics.”
 
The announcement was made Tuesday to coincide with the national awareness campaign Rare Disease Day.
 
The team members are based at the contract research organization’s various locations, with the center’s head, PPD Senior Vice President Karen Kaucic, working out of its Rockville, Maryland, office.

“The team will come together at regular intervals to meet face to face, with annual meetings planned at our Wilmington headquarters to align with the annual Rare Disease Day,” PPD spokesman Randy Buckwalter said. “There are six members on the steering committee and 23 members of the full center of excellence with global representation.”

Though the center is new, PPD has logged experience in the two areas, conducting more than 220 rare disease studies with more than 50,000 patients in the past five years, according to company officials.

In the U.S., a disease is considered rare if it affects under 200,000 people. Europe defines it as a disease affecting no more than five in 10,000 people.

“In the U.S. and Europe alone, as many as 60 million individuals are affected by one of the more than 6,000 identified rare diseases,” the news release stated.

And in the area of pediatric drug development, PPD has conducted more than 400 clinical trials during the past five years, enrolling more than 97,000 patients.

There also is overlap between the two patient populations, company officials said.

“With a great majority of rare diseases touching children,” Kaucic said, “we believe our approach will enable us to be a more connected and active partner.”
Ico insights

INSIGHTS

SPONSORS' CONTENT
Burrus rob headshot 300x300

PMBA Team Wins Value Added Award for Wattles

Robert Burrus - Cameron School of Business - University of North Carolina Wilmington
Davidmcgowanapi300x300

2017: Energy in the Spotlight

David McGowan, III - N.C. Petroleum Council; American Petroleum Institute-NC
Yasminheadshotwithlogo

Lessons In Success

Yasmin Tomkinson - Cape Fear Literacy Council

Trending News

Virginia-based Insurance Broker Acquires Wilmington Firm

Christina Haley O'Neal - Nov 20, 2017

United Airlines To Offer Two New Non-stop Routes To DC, Chicago

Christina Haley O'Neal - Nov 20, 2017

Industrial Supply Co. Growing, To Open N. College Road Storefront

Cece Nunn - Nov 20, 2017

In The Current Issue

Feeding Frenzy

Those who’ve worked around the local restaurant scene for years, or decades, have seen the constant stream of eateries that open in the area...


Going Online For Animal Welfare

Janelle Babington bears such passion for animals that she made it her business to channel money to animal welfare organizations. She launche...


In Castle Hayne, A Better Business Crop

North Carolina farmers are getting the latest in tricks of the trade and technological advances through research being conducted at horticul...

Book On Business

The 2017 WilmingtonBiz: Book on Business is an annual publication showcasing the Wilmington region as a center of business.

Order Your Copy Today!


Galleries

Videos

2017 Health Care Heroes
Major Developments
WilmingtonBiz Expo - Key Note Lunch with Keynote Lunch with Chip Mahan - 2016